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Abstract: Plasmacytoid dendritic cells (pDCs) and neutrophils are detected in psoriatic skin lesions and implicated 
in the pathogenesis of psoriasis. pDCs specialize in the production of type I interferon (IFNI), a cytokine that plays 
an important role in chronic autoimmune-like inflammation, including psoriasis. Here, we demonstrate that IFNI 
production in pDCs is stimulated by DNA structures containing the neutrophil serine protease cathepsin G (CatG) 
and the secretory leukocyte protease inhibitor (SLPI), which is a controlling inhibitor of serine proteases. We also 
demonstrate the presence of neutrophil-derived DNA structures containing CatG and SLPI in lesional skin samples 
from psoriasis patients. These findings suggest a previously unappreciated role for CatG in psoriasis by linking CatG 
and its inhibitor SLPI to the IFNI-dependent regulation of immune responses by pDCs in psoriatic skin.
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Introduction
Plasmacytoid dendritic cells (pDCs) constitute 
a distinct subset of dendritic cells that special-
izes in the rapid and robust production of type I 
interferons (IFNI) such as IFN-α and IFN-β in 
response to the activation of the Toll-like recep-
tors TLR7 and TLR9 [1]. These endosome-local-
ized TLR receptors allow pDCs to uniquely 
respond to pathogen-derived nucleic acids and, 
through the production of IFNI, to inhibit viral 
replication and activate immune responses [2]. 
In addition to their contribution to antiviral 
defenses, pDCs have emerged as a pivotal cell 
type in autoimmune and chronic autoinflamma-
tory conditions such as systemic lupus erythe-
matosus (SLE) and psoriasis [3-6]. The contri-
bution of pDCs to these disorders is largely 
attributed to the production of IFNI by these 
cells following the activation of TLR9 by endog-
enous DNA. Although pDCs normally do not 
respond to host DNA, self-DNA can also trigger 
the production of INFI by pDCs if it reaches the 
DNA sensors inside the cell. The delivery of 
self-DNA to endosomal TLR9 was first reported 
to require the coupling of the DNA to an anti-
microbial peptide of the cathelicidin family of 
proteins, LL-37 [5]. Several other proteins/pep-
tides, primarily of neutrophil origin, have subse-
quently been identified along with DNA as 
potent triggers of IFNI in pDCs. These include 
the human neutrophil peptides of the α-defensin 
family [4], the high mobility group box 1 protein 
(HMGB) [3] and human neutrophil elastase 
(HNE) together with the secretory leukocyte 
proteinase inhibitor (SLPI) [7]. A candidate 
source of these molecules is the neutrophil 
extracellular trap (NET), which is a weblike 
structure that is composed of DNA as well as 
nuclear, granular and cytoplasmic proteins and 
is released by neutrophils into the extracellular 
environment [8].
The mechanisms that regulate NET formation 
are still largely unknown but are thought to 
involve several steps that are triggered by neu-
trophil activation. These steps include the pro-
duction of reactive oxygen species (ROS), the 
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disintegration of intracellular membranes and 
the translocation of HNE to the nucleus, fol-
lowed by chromatin decondensation, which is 
mediated by PAD4-dependent histone citrulina-
tion and/or HNE-dependent histone process-
ing. During the later phases of NET generation, 
the entire cell is filled with loose karyoplasm 
that mixes with the cytoplasm. Finally, the 
decondensed chromatin containing granular 
and cytoplasmic proteins is deposited extracel-
lularly [9-12].
Although it can be envisaged that the various 
proteins exposed on the NET are equipped with 
pDC-activating functions, we recently demon-
strated that this process may be protein-specif-
ic. Whereas HNE together with SLPI and DNA 
induced marked production of IFNI by pDCs, 
another protein closely related to HNE, azuroci-
din, did not stimulate IFNI synthesis under the 
same experimental conditions [7]. Azurocidin, 
similarly to HNE, was identified as a component 
of the NET by a proteomic analysis [8]. 
Therefore, these data suggest that NET pro-
teins differ in their ability to trigger IFNI produc-
tion by pDCs. Because pDCs play a key role in 
psoriasis, it is important to identify the NET 
components that stimulate these cells.
Figure 1. CatG- and SLPIcontaining NETs are present in psoriatic skin. Fluorescence microscopy images of lesional 
skin stained for CatG (red), SLPI (green) and DNA (blue). Netting cells (A-C), enlarged in (D), were identified by diffuse 
nuclei (demonstrating a lower-intensity Hoechst staining pattern), intracellular chromatin dispersion or extracellular 
fibrous DNA deposits. Cells with dispersed chromatin that co-stained with CatG and SLPI are shown by arrows. Neu-
trophils undergoing CatG release that is not associated with DNA and/or SLPI are shown by asterisks. Arrowheads 
highlight CatGSLPI-DNA co-localization at the cell surface. Data are from one donor and are representative of at 
least three donors. Scale bar = 10 µm.
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HNE and cathepsin G (CatG) are serine prote-
ases that are stored in the primary (azurophil) 
granules of neutrophils [13]. They share many 
functions that are primarily related to their pro-
teolytic activity, including the processing/deg-
radation of cell surface and extracellular matrix 
molecules [13, 14]. Both proteases are inhibit-
ed by SLPI, which is an inhibitor expressed by 
keratinocytes and immune cells such as granu-
locytes in psoriatic skin [7, 15, 16]. Because 
CatG, similarly to  HNE, is deposited by neutro-
phils into the extracellular milieu either through 
extracellular discharge of the granules’ con-
tents or through NET expulsion, it may partici-
pate in the pathogenesis of psoriasis as a solu-
ble molecule and/or a NET constituent.
In this study we report that CatG, similarly to 
HNE, co-localizes with SLPI and DNA deposits 
in psoriatic skin and, together with DNA and 
SLPI, strongly stimulates pDCs to secrete IFNI. 
These data place CatG and SLPI in a pathway 
that regulates pDC activation in psoriasis.
Materials and methods
Materials
Recombinant SLPI was purchased from R&D 
Systems. HNE and CatG were isolated using 
fresh whole human blood from healthy donors 
as a starting material, as previously described 
[17]. Pig pancreatic trypsin and bovine 
α-chymotrypsin were active-site-titrated with 
p-nitrophenyl guanidobenzoate [18] or p-nitro-
phenyl acetate [19] and used to standardize a 
solution of human α1-PI and α1-anti-
chymotrypsin (ACH), respectively. The final 
inhibitor preparations were more than 95% 
pure and 80% active. These inhibitors were 
then used as a secondary standard to deter-
mine the activity of HNE and CatG. Activity was 
measured in 0.1 M Tris-HCl and 0.5 M NaCl, pH 
7.4, using 0.5 mM MeO-Suc-Ala-Ala-Pro-Val-
pNA or Suc-Ala-Ala-Pro-Phe-pNA as a substrate, 
respectively. The final preparations of HNE and 
CatG were more than 95% pure and 90% active. 
The protein content in the HNE and CatG prepa-
rations was estimated using an A280 (1%) of 
9.85 or 6.64, respectively. Human plasma ACH 
was isolated as previously described [20]. 
Human genomic DNA was isolated from periph-
eral blood neutrophils of healthy donors using a 
method based on guanidine thiocyanate (GTC). 
GTC lysates were extracted using phenol: chlo-
roform. DNA was precipitated from the water 
phase using isopropanol and resuspended in 
TE buffer, as previously described [21]. The 
DNA purity, as measured as the A260/A280 
ratio, was between 1.8 and 2.0. Bafilomycin A1 
was obtained from Sigma-Aldrich.
Patients
All human studies were performed in accor-
dance with the guidelines established by the 
Jagiellonian University Institutional Bioethics 
Committee, under approved protocols. The 
Declaration of Helsinki protocols were followed. 
In total, six psoriasis patients (age 28.7 ± 6.6 
years; F:M 2:4) and 20 healthy individuals (age 
28.7 ± 5.1 years; F:M 7:13) were enrolled in 
these studies. The severity of the psoriatic skin 
lesions was assessed according to the Psoriasis 
Area Severity Index score (PASI) (minimum, 0 
points; maximum, 72 points) and ranged from 
25.3 to 39.6 (mean ± SD 32.5 ± 5.4). Patients 
on UV therapy or systemic or local corticoste-
roid treatments were excluded from the stud-
ies. Healthy control subjects had no clinical 
signs of dermatologic diseases.
Isolation of pDCs and neutrophils
Human blood was collected, and the peripheral 
blood mononuclear cells (PBMC) and granulo-
cyte-enriched fractions were harvested follow-
ing LSM1077 (PAA Laboratories) gradient sepa-
ration, as described by the manufacturer. pDCs 
were enriched from PBMCs using negative 
selection with biotinylated mAbs directed 
against CD3, CD14, CD16, CD19, CD20 and 
CD56 along with anti-biotin MACS Microbeads 
(Miltenyi Biotech), according to the manufac-
turer’s recommendations. The cells were sepa-
rated by magnetic sorting using an AutoMACS. 
The pDCs purity was ~95%, as determined by 
CD123 and BDCA-2 immunoreactivity and flow 
cytometry analysis.
Neutrophils were further purified from the gran-
ulocyte-enriched fractions. The high-density 
fraction, containing neutrophils and erythro-
cytes, was mixed with a 1% solution of polyvinyl 
alcohol (Merck) in PBS and incubated for 20 
min at room temperature. Neutrophils were 
harvested from the upper phase and subjected 
to hypotonic lysis to remove contaminating red 
blood cells. The purity of the isolated cells was 
examined by flow cytometry based on FSC and 
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SSC parameters and/or HNE immunoreactivity. 
Granulocytes were routinely > 98% pure.
pDC treatment
Purified pDCs (5x104-5x105 cells) were seeded 
into round-bottom 96-well plates in 50 µl of 
RPMI. The factors were either added directly 
into pDC cultures, or first premixed with DNA or 
with each other in 10 µl RPMI, incubated for 15 
min at room temperature, diluted five times and 
added to the pDC cultures. The following fac-
tors were used at the indicated final concentra-
tions: CatG, HNE, SLPI and ACH (all at 1 µM), 
and/or human neutrophil-derived DNA at 2 µg/
ml. In the indicated experiments, bafilomycin 
was added 30 min before the addition of the 
premixed stimuli to the pDC cultures. The pDCs 
were then cultured at 37°C under 5% CO2 for 24 
h in RPMI supplemented with 10% FBS and 
human recombinant IL-3 (50 ng/ml) (Peprotech), 
which improves pDC survival in vitro. The condi-
tioned media were collected and centrifuged at 
500 g for 5 min to remove the cells and tested 
by ELISA. Cytotoxicity was evaluated based on 
colorimetric measurement of the activity of lac-
tate dehydrogenase (LDH) released from dam-
aged cells and by staining pDCs with propidium 
iodide and annexin V followed by flow cytome-
try. The viability pDCs after 24 h of culture in 
vitro was approximately 80-85%. Cell treatment 
with the indicated factors, including bafilomy-
cin, did not affect cell viability.
RT-qPCR
Total RNA was extracted as previously described 
[22] and converted to cDNA using NxGenTM 
M-MulV reverse transcriptase (Lucigen) with 
oligo-dT primers (Oligo.pl). Real time PCR was 
performed on the 7500 Fast system (Applied 
Biosystems) using SYBR Green I-containing uni-
versal PCR master mix (A&A Biotechnology) 
and primers specific for human IFN alpha (5’- 
ACCCATTTCAACCAGTCTAGCAG-3’, 5’-GTGGGT- 
TTGAGGCAGATCACA) and GAPDH (5’-CCGAGCC- 
ACATCGCTCAGAC-3’, 5’-GTTGAGGTCAATGAAGG- 
GGTC-3’). The relative gene expression normal-
ized to GAPDH was calculated using the 2-ΔΔCT 
method [23].
ELISA
IFNI levels were quantified by ELISA using 
human IFN-α-specific matched antibody pairs 
(eBioscience) according to the manufacturer’s 
recommendations. The reaction was developed 
using TMB substrate (BD Science).
Immunohistochemistry
Frozen 6 µm sections were prepared from skin 
biopsies. Sections were fixed in acetone, 
blocked with mouse IgG and stained with the 
following antibodies: first, biotin-mouse anti-
human SLPI (Abcam) and rabbit-anti human 
CatG (Athens Research and Technology), fol-
lowed by PE-streptavidin (BD Pharmingen) and 
APC-goat anti-rabbit IgG F(ab)2 (Jackson 
ImmunoResearch). The sections were counter-
stained with Hoechst 33258 (Invitrogen). 
Images were captured with a fully motorized 
fluorescence microscope (NIKON, Eclipse) and 
analyzed by NIS elements software (Nikon).
Results
To determine whether CatG co-localizes with 
DNA and SLPI in areas of skin inflammation, we 
immunohistochemically analyzed involved pso-
riatic skin, which is known to be abundantly 
infiltrated by neutrophils. As demonstrated in 
Figure 1, the skin contained CatG+ SLPI+ clus-
ters of neutrophils or numerous single neutro-
phils at various stages of activation. Although 
double-positive (CatG+, SLPI+) neutrophils 
were the predominant infiltrating cells, we also 
observed occasional immune cells that stained 
for SLPI but not for CatG, which suggests a 
smaller contribution from other SLPI+ cells. 
Several different patterns of CatG staining were 
observed; CatG was found bound to the extra-
cellular matrix scaffold, localized to the cell sur-
face, or associated with decondensed chroma-
tin in the extracellular milieu. Notably, SLPI 
often co-localized with CatG either at the cell 
surface or in diffuse chromatin material char-
acterized as NETs. However, in several cases 
we observed separate staining for SLPI and 
CatG (Figure 1).
Our previous immunohistochemical data dem-
onstrated that neutrophils are often found in 
close association with pDCs in psoriatic skin 
[7]. The presence of CatG- and SLPI-bearing 
DNA deposits in psoriatic skin suggests that 
the induction of IFNI synthesis by skin-infiltrat-
ing pDCs may depend on the presence of self-
DNA/CatG/SLPI complexes. To test whether 
such complexes can trigger the production of 
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IFNI by pDCs, we stimulated pDCs isolated from 
human blood of healthy donors with CatG and/
or SLPI coupled to neutrophil-derived DNA. As 
shown in Figure 2A, CatG/SLPI/DNA complex-
es significantly stimulated the production of 
IFNI by pDCs. CatG, SLPI or DNA alone was 
each insufficient to activate pDCs to secrete 
IFNI. However, the dual complex containing 
CatG and DNA showed an increased tendency 
to trigger the production of IFNI in pDCs (Figure 
2A), and the stimulatory effect was much stron-
ger for the dual complex containing CatG and 
SLPI. Because the effect of the dual complexes 
was much less apparent that that of the triple 
complex (Figure 2A), in subsequent experi-
ments we focused on the complex of DNA with 
CatG and SLPI.
We previously reported that a mixture of neu-
trophil DNA with HNE and SLPI was a very 
potent stimulator of pDCs [7]. We next evaluat-
ed whether HNE and CatG are equally effective 
in triggering IFNI production in pDCs by analyz-
ing IFNI levels in conditioned media of pDCs 
stimulated with CatG/SLPI/DNA or HNE/SLPI/
DNA for 24 h. The replacement of CatG with 
HNE resulted in a stronger response, which 
suggests that in comparison with HNE, CatG 
has a more limited effect on IFNI production 
(Figure 2B). To determine whether other endog-
enous CatG inhibitors are capable of inducing 
IFNI in pDCs, we replaced SLPI with 
α1antichymotrypsin (ACH). ACH is the domi-
nant inhibitor of CatG and other chymotrypsin-
like enzymes, and it is abundantly produced by 
the liver and to a lesser extent by epithelial 
cells [24, 25]. Therefore, ACH may be present in 
psoriatic skin because of diffusion from blood 
plasma or local production by the skin epitheli-
um. As demonstrated in Figure 2B, in contrast 
to SLPI, ACH in complex with CatG and DNA did 
not stimulate IFNI production in pDCs. Given 
that replacement of SLPI with ACH resulted in a 
lack of IFNI production by pDCs, these data 
suggest a selective role for SLPI in controlling 
the serine-protease-mediated activation of 
DNA sensors in pDCs.
To determine whether self-DNA-dependent IFNI 
production by pDCs is induced by endosome-
localized TLRs, pDCs were pretreated with 
bafilomycin, which is a specific inhibitor of vac-
uolar-type H+ ATPase and thus inhibits the 
acidification of vacuolar compartments. 
Because endosomal acidification is required 
for endosomal TLR signaling, bafilomycin is 
Figure 2. IFNI production is stimulated by CatG- and SLPI-binding DNA structures. Purified pDCs were stimulated 
with the indicated factors, which were added directly into the pDC culture or were first premixed with DNA or each 
other. The final concentrations of the factors were as follows: DNA, 2 µg/ml; CatG, HNE, SLPI and ACH, 1 µM. Super-
natants of stimulated pDCs were collected and the IFNI levels were determined by ELISA. The amount of secreted 
IFNI is displayed as pg/ml. Each data point represents one experiment, and the mean value in each group, i.e., n = 
4-7 (A) or n = 5-14 (B), is indicated by a horizontal line. Statistically significant differences between untreated cells 
and treated cells (A) or CatG/SLPI/DNA and HNE/SLPI/DNA (B) are shown with the p value from a paired, two-tailed 
Student’s t test. (Data with p < 0.05 were considered statistically significant).
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used as a specific inhibitor of endosomal TLRs 
activation [26]. As demonstrated in Figure 3, 
bafilomycin markedly inhibited DNA/CatG/
SLPI-mediated IFNI production by pDCs at the 
mRNA and protein levels. These findings sup-
port the involvement of TLR9 in the induction of 
IFNI by CatG- and SLPI-bearing DNA.
Discussion
In this study, we identified the NET component 
CatG as an effective trigger of IFNI production 
in pDCs. Our data suggest that CatG is likely to 
play a role in the activation of pDCs by allowing 
TLR9 to sense extracellular self-DNA. However, 
to efficiently deliver endogenous DNA to TLR9, 
CatG appears to require SLPI because in the 
absence of SLPI, the synthesis of IFNI was neg-
ligible or much less apparent. In this regard, we 
also demonstrated the presence of CatG- and 
SLPI-enriched DNA deposits in the lesional skin 
of psoriasis patients, which suggests that 
these structures may contribute to psoriasis by 
inducing IFNI production by pDCs that have 
been recruited to the skin.
Based on in vitro studies, human CatG has long 
been proposed to be involved in inflammatory 
processes through the proteolytic modification 
or cleavage of many proteins, including bacte-
rial virulence factors [14, 27]. In addition, this 
protease was reported to have antibacterial 
activity that is independent of its enzymatic 
function [28], which suggests that it contrib-
utes on multiple levels to antimicrobial defens-
es. Human and mouse CatG differ in substrate 
specificity, and this difference is mainly attrib-
uted to peptide cleavage at basic (tryptic) and 
aromatic (chymotryptic) sites by human 
enzymes, with a lack of tryptic activity but high-
er chymotryptic activity for mouse CatG [29]. 
However, mice deficient in CatG are more sus-
ceptible to fungal and bacterial infections, for 
example in models of lung infection with 
Streptococcus pneumoniae or intravenous 
injection of S. aureus or Aspergillus fumigatus 
[30-32]. Together, these observations support 
a protective role for CatG in immunity against 
pathogens. In contrast, in a non-infectious 
mouse model of renal ischemia-reperfusion 
injury or acute arthritis induced by passive 
transfer of monoclonal antibodies against type 
II collagen, an absence of CatG resulted in 
decreased inflammation and tissue damage 
[33, 34], which indicates that CatG is also an 
important component of tissue injury. The 
defensive and/or pro-inflammatory functions of 
CatG may be mediated by intracellular protein 
hydrolysis within lysosomes and/or cleavage of 
extracellular substrates following the release of 
CatG from activated neutrophils. In addition, 
CatG may localize to the cell surface, where it 
remains catalytically active and possibly resis-
tant to inhibition by naturally occurring protein-
Figure 3. CatG/SLPI/DNA complexes stimulate IFNI production via endosome-localized receptors. Purified pDCs 
were stimulated for 24 h with the indicated factors: DNA, 2 µg/ml; CatG and SLPI, 1 µM. Bafilomycin (Bafi) was pre-
incubated with the pDCs at 25 nM for 30 min, followed by the addition of the CatG/SLPI/DNA mixture. Cells and 
supernatants were collected and subjected to RT-qPCR (A) or ELISA (B). A. The IFNI expression data are normalized 
to GAPDH and presented relative to unstimulated cells. The mean ± SD of three independent experiments is shown. 
B. IFNI levels in conditioned media are displayed as pg/ml. The mean ± SD of three independent experiments is 
shown.
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ase inhibitors [35]. In a cell surface-bound 
state, CatG regulates neutrophil effector func-
tions such as integrin clustering, which is 
required for cell spreading and ROS production 
[36]. In agreement with the observation of CatG 
plasma membrane expression by activated 
neutrophils, our data indicate that high levels 
of CatG are associated with the cell surface in 
neutrophils that are infiltrating psoriatic skin. 
Although cell-surface-bound CatG has been 
proposed to be a secreted protease loaded 
onto binding sites on the cell membrane [35], in 
view of recent findings, it is also likely that neu-
trophils undergoing NET formation expose CatG 
at some point at the cell surface. If so, CatG in 
combination with SLPI and DNA at the cell 
membrane of skin-recruited neutrophils may 
be well-suited to activate pDCs, which, as we 
have demonstrated previously, are in contact 
with neutrophils in psoriatic skin [7]. 
Alternatively, the association of CatG with SLPI 
at the cell surface may represent a control 
mechanism to limit excessive proteolysis or 
other CatG-mediated functions.
In addition to the DNA decorated with CatG and 
SLPI that is found at the neutrophil surface, we 
also noted CatG- and SLPI-enriched DNA 
deposits in the extracellular environment of 
psoriatic skin. These deposits resembled, to 
some degree, the HNE- and SLPI-containing 
NETs that we reported previously in the lesional 
skin of patients suffering from psoriasis [7]. 
Although it remains to be determined whether 
CatG and HNE co-localize on NETs in lesional 
skin, it is likely that these enzymes have, at 
least to some degree, diverse distributions on 
DNA deposits. Although they have similar bio-
chemical and physiological features, CatG and 
HNE differ in several properties, most notably 
in their ability to promote the nuclear decon-
densation that precedes NET release, which is 
attributed to HNE but not to CatG [11]. 
Therefore, the coupling of HNE and CatG to 
DNA may be separated in time and/or in space, 
thus resulting in a distinct pattern of HNE and 
CatG distribution on NETs.
Another intriguing aspect of our studies is the 
dependence of HNE and CatG on SLPI for effec-
tively controlling the immunogenicity of extra-
cellular self-DNA ([7] and present studies). 
Several of the most potent known inhibitors of 
HNE and CatG, such as α1-proteinase inhibitor, 
ACH and SLPI, may be present in psoriatic skin, 
either delivered by plasma or serum influx to 
the afflicted tissue or produced locally by kera-
tinocytes or immune cells. However, in contrast 
to SLPI, neither α1-proteinase inhibitor nor ACH 
was effective in stimulating IFNI production by 
pDCs when combined with self-DNA and HNE or 
CatG, respectively ([7] and present studies). 
These data suggest that regulation of the cata-
lytic activity of serine proteases may not be a 
unifying or sufficient property for an inhibitor to 
support IFNI production by pDCs in response to 
self-DNA. In future work, it would be interesting 
to determine what structural or functional 
assets of SLPI are responsible for its unique 
cooperation with neutrophil proteases for the 
delivery of self-DNA to TLR9.
The IFNI that is produced by pDCs following 
stimulation by NETs has been reported to pro-
mote autoinflammatory conditions such as SLE 
[3, 4]. In contrast, lupus-prone mice that are 
unable to generate NETs because of a deficien-
cy in NADPH oxidase (Nox2) demonstrate more 
severe lupus than their Nox2-sufficient counter-
parts [37], which supports the importance of 
NETs in homeostasis. Our findings that DNA/
CatG/SLPI complexes in the skin can stimulate 
IFNI production in pDCs raise the question of 
whether these structures promote the pro-
inflammatory responses of pDCs that support 
the initiation and/or augmentation of psoriasis, 
and/or contribute to the resolution of inflamma-
tion in psoriatic skin through IFNI. Notably, 
pDC-derived IFNI also has been proposed to 
promote wound healing following skin injury 
[38]. Therefore, although aberrant production 
of IFNI by activated pDCs may exacerbate the 
symptoms of psoriasis, IFNI secretion by these 
cells following stimulation with self-DNA in a 
complex with CatG or HNE and SLPI is also like-
ly to play an anti-inflammatory role in psoriasis 
by supporting a healing response in the dam-
aged skin. Our discovery of CatG/SLPI/DNA-
mediated IFNI production by pDCs may contrib-
ute to a better understanding of the growing 
complexity of NETs in auto-inflammatory 
diseases.
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